Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus‐related cirrhosis-Reference-Cited by-同舟云学术

Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus‐related cirrhosis

Published:2021-09-17 Issue:11 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Abdel Moneim Mai¹,Abdelaziz Doaa H.¹²,Ibrahim Nagy Yosra³,Abdel Baki Amin⁴,Attia Ahmed S.³,Sabry Nirmeen⁵

Affiliation:

1. Clinical Pharmacy Department The National Hepatology and Tropical Medicine Research Institute Cairo Egypt

2. Clinical Pharmacy and Pharmacy Practice Department Faculty of Pharmacy Future University in Egypt Cairo Egypt

3. Department of Microbiology and Immunology Faculty of Pharmacy Cairo University Cairo Egypt

4. Hepatology, Gastroenterology and Infectious Diseases Department The National Hepatology and Tropical Medicine Research Institute Cairo Egypt

5. Clinical Pharmacy Department Faculty of Pharmacy Cairo University Cairo Egypt

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14807

Reference58 articles.

1. Towards a hepatitis free Egypt: is this achievable?

2. Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway

3. Review article: the burden of hepatic encephalopathy

4. Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases

5. Hospitalizations During the Use of Rifaximin Versus Lactulose for the Treatment of Hepatic Encephalopathy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review;Archiv der Pharmazie;2024-07-23

2. Prophylaxis of hepatic encephalopathy: current and future drug targets;Hepatology International;2024-03-16

3. Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis;BMC Gastroenterology;2024-03-04

4. Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis;Cureus;2024-01-31

5. Modern Possibilities of Using Lactulose in Clinical Practice;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-10-31